A more recent version of this regulatory record is available. This version is kept only as a historical record. Please see the Record history section for link to the most recent version.

Perfluorooctanoic acid and its salts

List details

Basic info

Status Submitted
Submitter Germany
Co-submitter Norway
Details on the scope of restriction Shall not be manufactured, used or placed on the market as substances on their own, as constituents of other substances, in a mixture or in articles.
Further substance information Perfluorooctanoic acid (PFOA, CAS 335-67-1, EC 206-397-9), and any other linear or branched perfluoroheptyl derivative with the formula C7F15-X and any linear or branched perfluorooctyl derivative with the formula C8F17-X (where X=any group, including salts, other than F, Cl, Br), except those derivatives with the formula C8F17-SO2X', C8F17-C(=O)OH or C8F17-CF2-X' (where X'=any group, including salts)
Reason for restriction PFOA is not degradable, accumulates in organisms and is toxic (REACH Art. 57 c and d; CMR and PBT). Precursor substances (PFOA-related substances) can be degraded to PFOA in the environment. PFOA as well as PFOA-related substances can be found in consumer articles and during the life-cycle of these articles these substances can be released into the environment. Both, PFOA and its precursors, are man-made chemicals without known natural sources. Nevertheless, PFOA as well as precursors can be found in all environmental media including remote regions like the Arctic. Humans are exposed to PFOA and PFOA-related substances mainly via food, drinking water and indoor air. PFOA can be found in human blood of the general population and is transferred to foetus within the mothers’ body or via breast milk. Half-life of PFOA in the human body is approximately 3.5 years.

Intention timeline

Date of intention 2014-02-19
Expected date of submission 2014-10-17
Latest update 2018-12-21

Support information

Restriction report and annexes
Remarks The compilation of the Annex XV-Dossier is carried out as a joint project between the German CA and the Norwegian CA

Related substances

By adding any of the following substances to your watchlist, you would be monitoring this regulatory record and all possible new regulatory records related to that substance.

Related regulatory records

Record history

The following timeline shows when we detected changes of this regulatory record (the date might slightly differ from the date of the actual change). Additions between versions are hightlighted in green color, red color shows data removed between versions.

Feb. 8, 2019
  • Co-submitter: Norway
  • Details on the scope of restriction: Shall not be manufactured, used or placed on the market as substances on their own, as constituents of other substances, in a mixture or in articles.Perfluorooctanoic acid (PFOA, CAS 335-67-1, EC 206-397-9), and any other linear or branched perfluoroheptyl derivative with the formula C7F15-X and any linear or branched perfluorooctyl derivative with the formula C8F17-X (where X=any group, including salts, other than F, Cl, Br), except those derivatives with the formula C8F17-SO2X', C8F17-C(=O)OH or C8F17-CF2-X' (where X'=any group, including salts) shall not be manufactured, used or placed on the market as substances on their own, as constituents of other substances, in a mixture or in articles.
  • Latest update: 2018-12-212019-02-07
  • Restriction report and annexes: https://echa.europa.eu/documents/10162/5ee50cb3-40b4-aad4-9d66-f5995b5eb2eahttps://echa.europa.eu/documents/10162/d0bbb62e-2c61-63cf-16f5-16f1e06b7511
  • Status: SubmittedCommission decided
  • Submitter: Germany
Feb. 18, 2019
  • Latest update: 2019-02-072018-12-21
This version
Jan. 3, 2019
  • Latest update: 2018-12-182018-12-21
Dec. 18, 2018
  • Latest update: 2018-08-292018-12-18
  • Restriction report and annexes: https://echa.europa.eu/documents/10162/5ac240df-22bf-224a-693e-058bf2004245https://echa.europa.eu/documents/10162/5ee50cb3-40b4-aad4-9d66-f5995b5eb2ea
Add the related substance to your watchlist to monitor this regulatory record.